|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5575 | |
| A61K 9/00 | |||
| A61K 47/18 | |||
| A61P 27/06 |
| (11) | Patento numeris | 2501388 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10787055.2 |
| Europos patento paraiškos padavimo data | 2010-11-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-09-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/067846 |
| Data | 2010-11-19 |
| (87) | Numeris | WO 2011/061298 |
| Data | 2011-05-26 |
| (30) | Numeris | Data | Šalis |
| 262664 P | 2009-11-19 | US | |
| 10164376 | 2010-05-28 | EP |
| (72) |
GARRIGUE, Jean-Sébastien, FR
LALLEMAND, Frédéric, FR
DAULL, Philippe, FR
BAUDOUIN, Christophe, FR
|
| (73) |
Santen SAS,
1, rue Pierre Fontaine Bātiment Genavenir IV, 91000 Evry,
FR
|
| (54) | USE OF PROSTAGLANDINS F2ALPHA AND ANALOGUES FOR THE HEALING OF CORNEAL AND CONJUNCTIVAL LESIONS |
| USE OF PROSTAGLANDINS F2ALPHA AND ANALOGUES FOR THE HEALING OF CORNEAL AND CONJUNCTIVAL LESIONS |